查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128132

藥物發現服務市場規模、佔有率、成長、全球產業分析、區域趨勢以及 2026 年至 2034 年的預測。

Drug Discovery Services Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 2-3個工作天內

價格

藥物研發服務市場的成長要素

全球藥物研發服務市場預計到2025年將達到197.6億美元，2026年成長至211.1億美元，2034年達到362.2億美元，預測期內複合年成長率（CAGR）為7.0%。北美地區憑藉強大的藥物研發實力、先進的生物技術基礎設施以及研發活動外包的日益成長，預計將在2025年佔市場主導地位，市場佔有率達39.62%。

藥物發現服務在製藥和生物技術公司中發揮著至關重要的作用，它們負責在臨床開發之前識別、檢驗和最佳化候選藥物。這些服務包括藥物化學、生物學研究、先導化合物最佳化、標靶識別、毒理學和生物標記發現。對創新療法日益成長的需求、慢性病患病率的上升、生物技術領域研發管線的擴展以及合約研究組織 (CRO) 與製藥公司之間合作的加強，持續推動著市場成長。人工智慧 (AI)、自動化和計算生物學的融合進一步提高了研究效率，並縮短了藥物開發週期。

市場趨勢

藥物研發服務市場正在經歷變革，其中一個關鍵趨勢是人工智慧、機器學習和自動化技術在整個藥物研發流程中的應用日益廣泛。人工智慧平台正在加速標靶識別、虛擬篩檢、先導藥物最適化、生物標記發現和ADMET預測，同時降低研發成本並提高成功率。自動化實驗室系統、雲端研究平台和運算生物學工具使合約研究組織（CRO）能夠更快、更準確地交付成果。製藥公司正在擴大與提供整合式數位化藥物研發解決方案的專業服務供應商的合作，從而加強長期的外包關係。

市場促進因素

隨著癌症、心血管疾病、神經系統疾病和罕見遺傳疾病等慢性病的日益普遍，新療法的需求顯著成長。製藥和生技公司擴大將早期藥物研發活動外包給專業的合約研究組織（CRO），以拓展研發管線、降低研發成本並加速商業化進程。

對生物技術研究、個人化醫療、孤兒藥研發和精準治療的投入增加，也推動了市場擴張。學術機構、製藥公司和合約研究機構（CRO）之間合作的加強，進一步促進了全球藥物研發計畫的創新。

市場限制因素

儘管市場成長前景強勁，但由於先進藥物研發技術高成本，市場仍面臨挑戰。現代藥物研發平台需要對高通量篩檢系統、冷凍電鏡、人工智慧軟體、實驗室自動化、生物資訊基礎設施以及經驗豐富的科研人員進行大量投資。這些巨額資金需求使得小規模的生技公司和新興的合約研究機構（CRO）難以獲得先進的藥物研發能力。

市場機遇

新興經濟體醫藥外包業務的擴張為市場帶來了巨大的成長機會。中國和印度等國家持續增加對生物技術基礎設施、研究設施和合約研究組織（CRO）能力建設的投資。政府對生命科學的扶持力度加大、營運成本降低、高技能科研人才的湧現以及醫藥製造生態系統的不斷完善，都吸引著全球外包合約的湧入。那些能夠提供整合化學、生物學、計算建模和人工智慧等技術的藥物研發服務的公司，預計將從日益成長的國際需求中獲益。

市場挑戰

主要挑戰之一是部分新興經濟體中高度專業化的合約研究組織（CRO）數量有限。藥物化學、轉化生物學、毒理學、電腦輔助藥物設計和高通量篩檢等先進能力仍集中在少數幾個機構。此外，對於許多服務供應商而言，在拓展全球業務的同時，如何保持合規性、資料完整性、智慧財產權保護和科學專業知識仍然是一項挑戰。

細分分析

就服務類型而言，預計到2025年，化學服務領域將佔最大的市場佔有率，這主要得益於其在化合物合成、藥物化學、分析化學以及小分子藥物研發整體的先導藥物最適化等方面的廣泛應用。生物服務領域預計將實現強勁成長，這主要得益於體外分析、毒性測試和生物標記研究需求的不斷成長。

以藥物發現階段來看，先導化合物最佳化先導藥物最適化市場成長，這主要得益於製藥公司擴大將綜合化學和生物服務外包，以改善候選化合物的選擇並縮短開發週期。

從藥物類型來看，小分子藥物（SMO）佔最大的市場佔有率，這主要得益於一系列小分子藥物的批准以及慢性病治療需求的不斷成長。此外，由於對生物製藥和生物相似藥的投資增加，生物製藥市場預計將穩定擴張。

就治療領域而言，受全球癌症發病率上升、癌症臨床研究不斷擴大以及精準醫療投入不斷增加的推動，腫瘤學在2025年仍將保持領先地位。神經系統疾病領域預計也將強勁成長，這主要得益於帕金森氏症、阿茲海默症、癲癇和其他神經系統疾病研究的持續深入。

按最終用戶分類，預計到 2025 年，製藥和生技公司將佔最大的銷售額。這是因為這些機構不斷將藥物研發活動外包，以提高效率、降低成本並加快產品開發。

區域展望

北美仍是最大的區域市場，預計到2025年將達到78.3億美元。該地區受益於強大的製藥產業、先進的合約研究組織（CRO）基礎設施、人工智慧（AI）的日益普及以及對生物技術研究的持續投入。美國市場預計2026年將達到74.6億美元，繼續維持在主導地位。

在製藥業研發投入增加、生技研究擴張以及政府對創新的大力支持下，預計2026年，歐洲研發市場規模將達到57.2億美元。德國和英國將繼續保持其作為該地區領先市場的地位。

預計到2026年，亞太地區市場規模將達到51.6億美元，主要驅動力包括藥品生產的擴張、醫療保健支出的成長、政府對生物技術的支持以及中國和印度合約研究組織（CRO）的快速發展。其中，中國預計到2026年將達到18億美元，而印度預計為9.7億美元。

在拉丁美洲、中東和非洲地區，由於對藥物研發的投資增加、醫療保健基礎設施的擴張以及參與全球臨床研究計畫的增加，預計將穩步成長。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家和地區主要疾病的流行情況
  • 2025年主要國家醫療保健支出概覽
  • 研發支出概覽，主要公司
  • 產業重大發展：合併、收購與合作。

第5章：全球藥物研發服務市場分析、洞察與預測（2021-2034年）

  • 市場分析、洞察與預測：按服務類型分類
    • 化學服務
      • 合成化學服務
      • 分析化學服務
      • 其他
    • 生物服務
      • 體外分析服務
      • 毒理學服務
      • 其他
  • 市場分析、洞察與預測：按藥物發現階段分類
    • 目標識別與檢驗
    • 命中識別
    • 點擊閱讀
    • 先導藥物最適化
    • 其他
  • 市場分析、洞察與預測：按藥物類型分類
    • 低分子化合物
    • 生物製劑
  • 市場分析、洞察與預測：按治療領域分類
    • 腫瘤學
    • 神經系統疾病
    • 感染疾病
    • 心血管疾病
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 製藥和生物技術公司
    • 學術研究機構
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美藥物研發服務市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲藥物研發服務市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區藥物研發服務市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲藥物研發服務市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲藥物研發服務市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Charles River Laboratories
    • WuXi AppTec
    • Labcorp
    • Evotec
    • Eurofins Scientific
    • Sygnature
    • Pharmaron
    • Aragen Life Sciences Ltd.
    • Sai Life Sciences Limited
    • Crown Bioscience
Product Code: FBI117651

Growth Factors of drug discovery services Market

The global drug discovery services market was valued at USD 19.76 billion in 2025 and is projected to grow from USD 21.11 billion in 2026 to USD 36.22 billion by 2034, registering a CAGR of 7.0% during the forecast period. North America dominated the market with a 39.62% share in 2025, supported by strong pharmaceutical research, advanced biotechnology infrastructure, and increasing outsourcing of research and development activities.

Drug discovery services play a critical role in helping pharmaceutical and biotechnology companies identify, validate, and optimize drug candidates before clinical development. These services include medicinal chemistry, biology studies, lead optimization, target identification, toxicology, and biomarker discovery. Growing demand for innovative therapies, rising chronic disease prevalence, expanding biotechnology pipelines, and increasing collaboration between contract research organizations (CROs) and pharmaceutical companies continue to drive market growth. The integration of artificial intelligence (AI), automation, and computational biology is further improving research efficiency and reducing drug development timelines.

Market Trends

A major trend transforming the drug discovery services market is the increasing use of artificial intelligence, machine learning, and automation across the drug discovery workflow. AI-powered platforms are accelerating target identification, virtual screening, lead optimization, biomarker discovery, and ADMET prediction while reducing research costs and improving success rates. Automated laboratory systems, cloud-based research platforms, and computational biology tools are enabling CROs to deliver faster and more accurate results. Pharmaceutical companies are increasingly partnering with specialized service providers that offer integrated digital discovery solutions, strengthening long-term outsourcing relationships.

Market Drivers

The growing prevalence of chronic diseases such as cancer, cardiovascular disorders, neurological diseases, and rare genetic disorders is significantly increasing demand for new therapeutic solutions. Pharmaceutical and biotechnology companies are expanding their research pipelines and increasingly outsourcing early-stage drug discovery activities to specialized CROs to reduce development costs and accelerate commercialization.

Growing investments in biotechnology research, personalized medicine, orphan drug development, and precision therapeutics are also supporting market expansion. Rising collaborations between academic institutions, pharmaceutical companies, and CROs continue to strengthen innovation across global drug discovery programs.

Market Restraints

Despite strong growth prospects, the market faces challenges due to the high cost of advanced drug discovery technologies. Modern discovery platforms require significant investments in high-throughput screening systems, cryo-electron microscopy, AI software, laboratory automation, bioinformatics infrastructure, and skilled scientific professionals. These high capital requirements make advanced discovery capabilities less accessible for small biotechnology firms and emerging CROs.

Market Opportunities

Expanding pharmaceutical outsourcing across emerging economies presents significant growth opportunities for the market. Countries such as China and India continue investing heavily in biotechnology infrastructure, research laboratories, and CRO capabilities. Increasing government support for life sciences, lower operational costs, skilled scientific talent, and expanding pharmaceutical manufacturing ecosystems are attracting global outsourcing contracts. Companies offering integrated chemistry, biology, computational modeling, and AI-enabled discovery services are expected to benefit from growing international demand.

Market Challenges

One of the major challenges is the limited availability of highly specialized CROs in several emerging economies. Advanced capabilities such as medicinal chemistry, translational biology, toxicology, computational drug design, and high-throughput screening remain concentrated among relatively few organizations. Maintaining regulatory compliance, data integrity, intellectual property protection, and scientific expertise while scaling global operations also remains challenging for many service providers.

Segmentation Analysis

Based on service type, the chemistry services segment accounted for the largest market share in 2025 due to its extensive use in compound synthesis, medicinal chemistry, analytical chemistry, and lead optimization throughout small-molecule drug development. The biology services segment is projected to witness strong growth owing to increasing demand for in-vitro profiling, toxicology studies, and biomarker research.

Based on discovery phase, lead optimization dominated the market in 2025 as pharmaceutical companies increasingly outsourced integrated chemistry and biology services to improve candidate selection and accelerate development timelines.

By drug type, the small molecules segment held the largest market share owing to continued approvals of small-molecule therapies and growing treatment demand for chronic diseases. The biologics segment is also expected to expand steadily with increasing investment in biologic therapies and biosimilars.

Based on therapeutic area, oncology remained the leading segment in 2025, driven by increasing global cancer incidence, rising oncology clinical research, and expanding precision medicine initiatives. Neurological diseases are expected to witness robust growth due to increasing research into Parkinson's disease, Alzheimer's disease, epilepsy, and other neurological disorders.

By end user, pharmaceutical and biotechnology companies accounted for the largest revenue share in 2025 as these organizations continue outsourcing discovery activities to improve efficiency, reduce costs, and accelerate product development.

Regional Outlook

North America remained the largest regional market, reaching USD 7.83 billion in 2025. The region benefits from a strong pharmaceutical industry, advanced CRO infrastructure, increasing AI adoption, and continuous investment in biotechnology research. The U.S. market is estimated to reach USD 7.46 billion in 2026, maintaining its leadership in outsourced drug discovery services.

Europe is projected to reach USD 5.72 billion in 2026, supported by increasing pharmaceutical R&D investments, expanding biotechnology research, and strong government support for innovation. Germany and the U.K. continue to represent major regional markets.

Asia Pacific is expected to reach USD 5.16 billion in 2026, driven by expanding pharmaceutical manufacturing, increasing healthcare expenditure, government support for biotechnology, and rapid CRO expansion across China and India. China is projected to reach USD 1.80 billion in 2026, while India is estimated at USD 0.97 billion.

Latin America and the Middle East & Africa are expected to witness steady growth due to increasing pharmaceutical research investments, expanding healthcare infrastructure, and growing participation in global clinical research programs.

Competitive Landscape

The global drug discovery services market is highly competitive, with companies focusing on expanding integrated service portfolios, adopting AI-driven research platforms, strengthening global laboratory networks, and pursuing strategic collaborations. Major market participants include Charles River Laboratories, WuXi AppTec, Labcorp, Evotec, Eurofins Scientific, Sygnature, Pharmaron, Aragen Life Sciences, Sai Life Sciences, and Crown Bioscience.

Recent industry developments demonstrate continued investment in artificial intelligence, biologics capabilities, next-generation sequencing, computational chemistry, and strategic acquisitions. Partnerships between CROs and AI technology providers are improving discovery efficiency while enabling pharmaceutical companies to accelerate innovation across multiple therapeutic areas.

Conclusion

The global drug discovery services market is expected to witness sustained growth through 2034, supported by rising pharmaceutical outsourcing, increasing chronic disease burden, expanding biotechnology research, and continuous technological advancements in AI and laboratory automation. With the market expected to increase from USD 19.76 billion in 2025 to USD 21.11 billion in 2026 and further reach USD 36.22 billion by 2034, service providers offering integrated chemistry, biology, computational research, and digital drug discovery capabilities will remain well-positioned to capitalize on growing global demand.

Segmentation By Service Type, Discovery Phase, Drug Type, Therapeutic Area, End User, and Region

By Service Type * Chemistry Services

    • Synthetic Chemistry Services
    • Analytical Chemistry Services
    • Others
  • Biology Services
    • In-vitro Profiling Services
    • Toxicology Services
    • Others

By Discovery Phase * Target Identification & Validation

  • Hit Identification
  • Hit-to-Lead
  • Lead Optimization
  • Others

By Drug Type * Small Molecules

  • Biologics

By Therapeutic Area * Oncology

  • Neurological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

By End User * Pharmaceutical & Biotechnological Companies

  • Academic & Research Institutes
  • Others

By Region * North America (By Service Type, By Discovery Phase, By Drug Type, By Therapeutic Area, By End User, and by Country)

    • U.S. (By Drug Type)
    • Canada (By Drug Type)
  • Europe (By Service Type, By Discovery Phase, By Drug Type, By Therapeutic Area, By End User, and by Country/Sub-region)
    • U.K. (By Drug Type)
    • Germany (By Drug Type)
    • France (By Drug Type)
    • Italy (By Drug Type)
    • Spain (By Drug Type)
    • Scandinavia (By Drug Type)
    • Rest of Europe (By Drug Type)
  • Asia Pacific (By Service Type, By Discovery Phase, By Drug Type, By Therapeutic Area, By End User, and by Country/Sub-region)
    • China (By Drug Type)
    • Japan (By Drug Type)
    • India (By Drug Type)
    • Australia (By Drug Type)
    • Southeast Asia (By Drug Type)
    • Rest of Asia Pacific (By Drug Type)
  • Latin America (By Service Type, By Discovery Phase, By Drug Type, By Therapeutic Area, By End User, and by Country/Sub-region)
    • Brazil (By Drug Type)
    • Mexico (By Drug Type)
    • Rest of Latin America (By Drug Type)
  • Middle East & Africa (By Service Type, By Discovery Phase, By Drug Type, By Therapeutic Area, By End User, and by Country/Sub-region)
    • GCC (By Drug Type)
    • South Africa (By Drug Type)
    • Rest of Middle East & Africa (By Drug Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Challenges
  • 3.5. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Region, 2025
  • 4.2. Overview of Healthcare Expenditure, Key Countries, 2025
  • 4.3. Overview of R&D Expenditures, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Drug Discovery Services Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Service Type
    • 5.1.1. Chemistry Services
      • 5.1.1.1. Synthetic Chemistry Services
      • 5.1.1.2. Analytical Chemistry Services
      • 5.1.1.3. Others
    • 5.1.2. Biology Services
      • 5.1.2.1. In-vitro Profiling Services
      • 5.1.2.2. Toxicology Services
      • 5.1.2.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Discovery Phase
    • 5.2.1. Target Identification & Validation
    • 5.2.2. Hit Identification
    • 5.2.3. Hit-to-Lead
    • 5.2.4. Lead Optimization
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Drug Type
    • 5.3.1. Small Molecules
    • 5.3.2. Biologics
  • 5.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 5.4.1. Oncology
    • 5.4.2. Neurological Diseases
    • 5.4.3. Infectious Diseases
    • 5.4.4. Cardiovascular Diseases
    • 5.4.5. Others
  • 5.5. Market Analysis, Insights and Forecast - By End User
    • 5.5.1. Pharmaceutical & Biotechnological Companies
    • 5.5.2. Academic & Research Institutes
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Drug Discovery Services Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Service Type
    • 6.1.1. Chemistry Services
      • 6.1.1.1. Synthetic Chemistry Services
      • 6.1.1.2. Analytical Chemistry Services
      • 6.1.1.3. Others
    • 6.1.2. Biology Services
      • 6.1.2.1. In-vitro Profiling Services
      • 6.1.2.2. Toxicology Services
      • 6.1.2.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Discovery Phase
    • 6.2.1. Target Identification & Validation
    • 6.2.2. Hit Identification
    • 6.2.3. Hit-to-Lead
    • 6.2.4. Lead Optimization
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Drug Type
    • 6.3.1. Small Molecules
    • 6.3.2. Biologics
  • 6.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 6.4.1. Oncology
    • 6.4.2. Neurological Diseases
    • 6.4.3. Infectious Diseases
    • 6.4.4. Cardiovascular Diseases
    • 6.4.5. Others
  • 6.5. Market Analysis, Insights and Forecast - By End User
    • 6.5.1. Pharmaceutical & Biotechnological Companies
    • 6.5.2. Academic & Research Institutes
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
      • 6.6.1.1. By Drug Type
    • 6.6.2. Canada
      • 6.6.2.1. By Drug Type

7. Europe Drug Discovery Services Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Service Type
    • 7.1.1. Chemistry Services
      • 7.1.1.1. Synthetic Chemistry Services
      • 7.1.1.2. Analytical Chemistry Services
      • 7.1.1.3. Others
    • 7.1.2. Biology Services
      • 7.1.2.1. In-vitro Profiling Services
      • 7.1.2.2. Toxicology Services
      • 7.1.2.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Discovery Phase
    • 7.2.1. Target Identification & Validation
    • 7.2.2. Hit Identification
    • 7.2.3. Hit-to-Lead
    • 7.2.4. Lead Optimization
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Drug Type
    • 7.3.1. Small Molecules
    • 7.3.2. Biologics
  • 7.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 7.4.1. Oncology
    • 7.4.2. Neurological Diseases
    • 7.4.3. Infectious Diseases
    • 7.4.4. Cardiovascular Diseases
    • 7.4.5. Others
  • 7.5. Market Analysis, Insights and Forecast - By End User
    • 7.5.1. Pharmaceutical & Biotechnological Companies
    • 7.5.2. Academic & Research Institutes
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
      • 7.6.1.1. By Drug Type
    • 7.6.2. Germany
      • 7.6.2.1. By Drug Type
    • 7.6.3. France
      • 7.6.3.1. By Drug Type
    • 7.6.4. Spain
      • 7.6.4.1. By Drug Type
    • 7.6.5. Italy
      • 7.6.5.1. By Drug Type
    • 7.6.6. Scandinavia
      • 7.6.6.1. By Drug Type
    • 7.6.7. Rest of Europe
      • 7.6.7.1. By Drug Type

8. Asia Pacific Drug Discovery Services Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Service Type
    • 8.1.1. Chemistry Services
      • 8.1.1.1. Synthetic Chemistry Services
      • 8.1.1.2. Analytical Chemistry Services
      • 8.1.1.3. Others
    • 8.1.2. Biology Services
      • 8.1.2.1. In-vitro Profiling Services
      • 8.1.2.2. Toxicology Services
      • 8.1.2.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Discovery Phase
    • 8.2.1. Target Identification & Validation
    • 8.2.2. Hit Identification
    • 8.2.3. Hit-to-Lead
    • 8.2.4. Lead Optimization
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Drug Type
    • 8.3.1. Small Molecules
    • 8.3.2. Biologics
  • 8.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 8.4.1. Oncology
    • 8.4.2. Neurological Diseases
    • 8.4.3. Infectious Diseases
    • 8.4.4. Cardiovascular Diseases
    • 8.4.5. Others
  • 8.5. Market Analysis, Insights and Forecast - By End User
    • 8.5.1. Pharmaceutical & Biotechnological Companies
    • 8.5.2. Academic & Research Institutes
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
      • 8.6.1.1. By Drug Type
    • 8.6.2. Australia
      • 8.6.2.1. By Drug Type
    • 8.6.3. China
      • 8.6.3.1. By Drug Type
    • 8.6.4. India
      • 8.6.4.1. By Drug Type
    • 8.6.5. Southeast Asia
      • 8.6.5.1. By Drug Type
    • 8.6.6. Rest of Asia Pacific
      • 8.6.6.1. By Drug Type

9. Latin America Drug Discovery Services Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Service Type
    • 9.1.1. Chemistry Services
      • 9.1.1.1. Synthetic Chemistry Services
      • 9.1.1.2. Analytical Chemistry Services
      • 9.1.1.3. Others
    • 9.1.2. Biology Services
      • 9.1.2.1. In-vitro Profiling Services
      • 9.1.2.2. Toxicology Services
      • 9.1.2.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Discovery Phase
    • 9.2.1. Target Identification & Validation
    • 9.2.2. Hit Identification
    • 9.2.3. Hit-to-Lead
    • 9.2.4. Lead Optimization
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Drug Type
    • 9.3.1. Small Molecules
    • 9.3.2. Biologics
  • 9.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 9.4.1. Oncology
    • 9.4.2. Neurological Diseases
    • 9.4.3. Infectious Diseases
    • 9.4.4. Cardiovascular Diseases
    • 9.4.5. Others
  • 9.5. Market Analysis, Insights and Forecast - By End User
    • 9.5.1. Pharmaceutical & Biotechnological Companies
    • 9.5.2. Academic & Research Institutes
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
      • 9.6.1.1. By Drug Type
    • 9.6.2. Mexico
      • 9.6.2.1. By Drug Type
    • 9.6.3. Rest of Latin America
      • 9.6.3.1. By Drug Type

10. Middle East & Africa Drug Discovery Services Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Service Type
    • 10.1.1. Chemistry Services
      • 10.1.1.1. Synthetic Chemistry Services
      • 10.1.1.2. Analytical Chemistry Services
      • 10.1.1.3. Others
    • 10.1.2. Biology Services
      • 10.1.2.1. In-vitro Profiling Services
      • 10.1.2.2. Toxicology Services
      • 10.1.2.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Discovery Phase
    • 10.2.1. Target Identification & Validation
    • 10.2.2. Hit Identification
    • 10.2.3. Hit-to-Lead
    • 10.2.4. Lead Optimization
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Drug Type
    • 10.3.1. Small Molecules
    • 10.3.2. Biologics
  • 10.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 10.4.1. Oncology
    • 10.4.2. Neurological Diseases
    • 10.4.3. Infectious Diseases
    • 10.4.4. Cardiovascular Diseases
    • 10.4.5. Others
  • 10.5. Market Analysis, Insights and Forecast - By End User
    • 10.5.1. Pharmaceutical & Biotechnological Companies
    • 10.5.2. Academic & Research Institutes
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
      • 10.6.1.1. By Drug Type
    • 10.6.2. South Africa
      • 10.6.2.1. By Drug Type
    • 10.6.3. Rest of Middle East & Africa
      • 10.6.3.1. By Drug Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Charles River Laboratories
    • 11.2.2. WuXi AppTec
    • 11.2.3. Labcorp
    • 11.2.4. Evotec
    • 11.2.5. Eurofins Scientific
    • 11.2.6. Sygnature
    • 11.2.7. Pharmaron
    • 11.2.8. Aragen Life Sciences Ltd.
    • 11.2.9. Sai Life Sciences Limited
    • 11.2.10. Crown Bioscience

List of Tables

  • Table 1: Global Drug Discovery Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 2: Global Drug Discovery Services Market Revenue (USD billion) Forecast, by Chemistry Services, 2021-2034
  • Table 3: Global Drug Discovery Services Market Revenue (USD billion) Forecast, by Biology Services, 2021-2034
  • Table 4: Global Drug Discovery Services Market Revenue (USD billion) Forecast, by Discovery Phase, 2021-2034
  • Table 5: Global Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 6: Global Drug Discovery Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 7: Global Drug Discovery Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 8: Global Drug Discovery Services Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 9: North America Drug Discovery Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 10: North America Drug Discovery Services Market Revenue (USD billion) Forecast, by Chemistry Services, 2021-2034
  • Table 11: North America Drug Discovery Services Market Revenue (USD billion) Forecast, by Biology Services, 2021-2034
  • Table 12: North America Drug Discovery Services Market Revenue (USD billion) Forecast, by Discovery Phase, 2021-2034
  • Table 13: North America Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 14: North America Drug Discovery Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 15: North America Drug Discovery Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 16: North America Drug Discovery Services Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 17: U.S. Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 18: Canada Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 19: Europe Drug Discovery Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 20: Europe Drug Discovery Services Market Revenue (USD billion) Forecast, by Chemistry Services, 2021-2034
  • Table 21: Europe Drug Discovery Services Market Revenue (USD billion) Forecast, by Biology Services, 2021-2034
  • Table 22: Europe Drug Discovery Services Market Revenue (USD billion) Forecast, by Discovery Phase, 2021-2034
  • Table 23: Europe Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 24: Europe Drug Discovery Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 25: Europe Drug Discovery Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 26: Europe Drug Discovery Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 27: Germany Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 28: U.K. Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 29: France Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 30: Italy Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 31: Spain Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 32: Scandinavia Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 33: Rest of Europe Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 34: Asia Pacific Drug Discovery Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 35: Asia Pacific Drug Discovery Services Market Revenue (USD billion) Forecast, by Chemistry Services, 2021-2034
  • Table 36: Asia Pacific Drug Discovery Services Market Revenue (USD billion) Forecast, by Biology Services, 2021-2034
  • Table 37: Asia Pacific Drug Discovery Services Market Revenue (USD billion) Forecast, by Discovery Phase, 2021-2034
  • Table 38: Asia Pacific Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 39: Asia Pacific Drug Discovery Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 40: Asia Pacific Drug Discovery Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 41: Asia Pacific Drug Discovery Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 42: China Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 43: Japan Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 44: India Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 45: Australia Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 46: Southeast Asia Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 47: Rest of Asia Pacific Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 48: Latin America Drug Discovery Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 49: Latin America Drug Discovery Services Market Revenue (USD billion) Forecast, by Chemistry Services, 2021-2034
  • Table 50: Latin America Drug Discovery Services Market Revenue (USD billion) Forecast, by Biology Services, 2021-2034
  • Table 51: Latin America Drug Discovery Services Market Revenue (USD billion) Forecast, by Discovery Phase, 2021-2034
  • Table 52: Latin America Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 53: Latin America Drug Discovery Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 54: Latin America Drug Discovery Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 55: Latin America Drug Discovery Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 56: Brazil Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 57: Mexico Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 58: Rest of Latin America Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 59: Middle East & Africa Drug Discovery Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 60: Middle East & Africa Drug Discovery Services Market Revenue (USD billion) Forecast, by Chemistry Services, 2021-2034
  • Table 61: Middle East & Africa Drug Discovery Services Market Revenue (USD billion) Forecast, by Biology Services, 2021-2034
  • Table 62: Middle East & Africa Drug Discovery Services Market Revenue (USD billion) Forecast, by Discovery Phase, 2021-2034
  • Table 63: Middle East & Africa Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 64: Middle East & Africa Drug Discovery Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 65: Middle East & Africa Drug Discovery Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 66: Middle East & Africa Drug Discovery Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 67: GCC Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 68: South Africa Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 69: Rest of Middle East & Africa Drug Discovery Services Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034

List of Figures

  • Figure 1: Global Drug Discovery Services Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Drug Discovery Services Market Value Share (%), by Service Type, 2025 & 2034
  • Figure 3: Global Drug Discovery Services Market Value Share (%), by Discovery Phase, 2025 & 2034
  • Figure 4: Global Drug Discovery Services Market Value Share (%), by Drug Type, 2025 & 2034
  • Figure 5: Global Drug Discovery Services Market Value Share (%), by Therapeutic Area, 2025 & 2034
  • Figure 6: Global Drug Discovery Services Market Value Share (%), by End User, 2025 & 2034
  • Figure 7: Global Drug Discovery Services Market Value Share (%), by Region, 2025 & 2034
  • Figure 8: North America Drug Discovery Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 9: North America Drug Discovery Services Market Value Share (%), by Service Type, 2025
  • Figure 10: North America Drug Discovery Services Market Value (USD billion), by Discovery Phase, 2025 & 2034
  • Figure 11: North America Drug Discovery Services Market Value Share (%), by Discovery Phase, 2025
  • Figure 12: North America Drug Discovery Services Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 13: North America Drug Discovery Services Market Value Share (%), by Drug Type, 2025
  • Figure 14: North America Drug Discovery Services Market Value (USD billion), by Therapeutic Area, 2025 & 2034
  • Figure 15: North America Drug Discovery Services Market Value Share (%), by Therapeutic Area, 2025
  • Figure 16: North America Drug Discovery Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 17: North America Drug Discovery Services Market Value Share (%), by End User, 2025
  • Figure 18: North America Drug Discovery Services Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19: North America Drug Discovery Services Market Value Share (%), By Country, 2025
  • Figure 20: Europe Drug Discovery Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 21: Europe Drug Discovery Services Market Value Share (%), by Service Type, 2025
  • Figure 22: Europe Drug Discovery Services Market Value (USD billion), by Discovery Phase, 2025 & 2034
  • Figure 23: Europe Drug Discovery Services Market Value Share (%), by Discovery Phase, 2025
  • Figure 24: Europe Drug Discovery Services Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 25: Europe Drug Discovery Services Market Value Share (%), by Drug Type, 2025
  • Figure 26: Europe Drug Discovery Services Market Value (USD billion), by Therapeutic Area, 2025 & 2034
  • Figure 27: Europe Drug Discovery Services Market Value Share (%), by Therapeutic Area, 2025
  • Figure 28: Europe Drug Discovery Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 29: Europe Drug Discovery Services Market Value Share (%), by End User, 2025
  • Figure 30: Europe Drug Discovery Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe Drug Discovery Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific Drug Discovery Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 33: Asia Pacific Drug Discovery Services Market Value Share (%), by Service Type, 2025
  • Figure 34: Asia Pacific Drug Discovery Services Market Value (USD billion), by Discovery Phase, 2025 & 2034
  • Figure 35: Asia Pacific Drug Discovery Services Market Value Share (%), by Discovery Phase, 2025
  • Figure 36: Asia Pacific Drug Discovery Services Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 37: Asia Pacific Drug Discovery Services Market Value Share (%), by Drug Type, 2025
  • Figure 38: Asia Pacific Drug Discovery Services Market Value (USD billion), by Therapeutic Area, 2025 & 2034
  • Figure 39: Asia Pacific Drug Discovery Services Market Value Share (%), by Therapeutic Area, 2025
  • Figure 40: Asia Pacific Drug Discovery Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 41: Asia Pacific Drug Discovery Services Market Value Share (%), by End User, 2025
  • Figure 42: Asia Pacific Drug Discovery Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Drug Discovery Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America Drug Discovery Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 45: Latin America Drug Discovery Services Market Value Share (%), by Service Type, 2025
  • Figure 46: Latin America Drug Discovery Services Market Value (USD billion), by Discovery Phase, 2025 & 2034
  • Figure 47: Latin America Drug Discovery Services Market Value Share (%), by Discovery Phase, 2025
  • Figure 48: Latin America Drug Discovery Services Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 49: Latin America Drug Discovery Services Market Value Share (%), by Drug Type, 2025
  • Figure 50: Latin America Drug Discovery Services Market Value (USD billion), by Therapeutic Area, 2025 & 2034
  • Figure 51: Latin America Drug Discovery Services Market Value Share (%), by Therapeutic Area, 2025
  • Figure 52: Latin America Drug Discovery Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 53: Latin America Drug Discovery Services Market Value Share (%), by End User, 2025
  • Figure 54: Latin America Drug Discovery Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America Drug Discovery Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa Drug Discovery Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 57: Middle East & Africa Drug Discovery Services Market Value Share (%), by Service Type, 2025
  • Figure 58: Middle East & Africa Drug Discovery Services Market Value (USD billion), by Discovery Phase, 2025 & 2034
  • Figure 59: Middle East & Africa Drug Discovery Services Market Value Share (%), by Discovery Phase, 2025
  • Figure 60: Middle East & Africa Drug Discovery Services Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 61: Middle East & Africa Drug Discovery Services Market Value Share (%), by Drug Type, 2025
  • Figure 62: Middle East & Africa Drug Discovery Services Market Value (USD billion), by Therapeutic Area, 2025 & 2034
  • Figure 63: Middle East & Africa Drug Discovery Services Market Value Share (%), by Therapeutic Area, 2025
  • Figure 64: Middle East & Africa Drug Discovery Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 65: Middle East & Africa Drug Discovery Services Market Value Share (%), by End User, 2025
  • Figure 66: Middle East & Africa Drug Discovery Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Drug Discovery Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global Drug Discovery Services Market Share (%), By Company, 2025